OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
46
Results
Show all
Save search
Copy query
Show results for
Unknown
(46)
Publication Date
Release Date
2021
(14)
2022
(7)
2019
(7)
2020
(5)
2018
(4)
2023
(3)
2025
(2)
2024
(2)
2015
(2)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Genome sequencing reveals novel noncoding variants in PLA2G6 and LMNB1 causing progressive neurologic disease.
Not available
S-EPMC9000935
|
biostudies-literature
Cite
Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain.
Not available
S-EPMC8354857
|
biostudies-literature
Cite
Progressive cerebellar atrophy in a patient with complex II and III deficiency and a novel deleterious variant in SDHA: A Counseling Conundrum.
Not available
S-EPMC8222855
|
biostudies-literature
Cite
A description of novel variants and review of phenotypic spectrum in
UBA5
-related early epileptic encephalopathy.
Not available
S-EPMC8208045
|
biostudies-literature
Cite
De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects.
Not available
S-EPMC6817525
|
biostudies-literature
Cite
Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.
Not available
S-EPMC10932913
|
biostudies-literature
Cite
Drosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolution.
Not available
S-EPMC4426361
|
biostudies-literature
Cite
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Not available
S-EPMC8409975
|
biostudies-literature
Cite
BioTIME: A database of biodiversity time series for the Anthropocene.
Not available
S-EPMC6099392
|
biostudies-literature
Cite
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Not available
S-EPMC4486345
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets